Bill Text: NC S187 | 2013-2014 | Regular Session | Amended
Bill Title: PM2.5 Studies on Humans Unlawful
Spectrum: Partisan Bill (Republican 5-0)
Status: (Introduced - Dead) 2013-04-10 - Re-ref Com On Rules and Operations of the Senate [S187 Detail]
Download: North_Carolina-2013-S187-Amended.html
GENERAL ASSEMBLY OF NORTH CAROLINA
SESSION 2013
S 1
SENATE BILL 187
|
Short Title: PM2.5 Studies on Humans Unlawful. |
(Public) |
|
|
Sponsors: |
Senators Rabon, Wade, Barefoot (Primary Sponsors); J. Davis and Newton. |
|
|
Referred to: |
Health Care. |
|
March 6, 2013
A BILL TO BE ENTITLED
AN ACT to make research studies on humans using fine particulate matter, known as pm2.5, unlawful and to direct the commission for public health to study and make recommendations to the general assembly regarding Research involving human subjects.
The General Assembly of North Carolina enacts:
SECTION 1. Article 8 of Chapter 14 of the General Statutes is amended by adding a new section to read:
"§ 14‑34.4A. Human research studies involving intentional exposure to fine particulate matter.
(a) It is unlawful for any person to conduct research studies that intentionally expose human subjects to fine particulate matter at a concentration higher than 12 micrograms per cubic meter or the primary annual health national ambient air quality standard, as defined by the United States Environmental Protection Agency, whichever is lower. For purposes of this section, "fine particulate matter" shall be defined as airborne particles with a diameter of 2.5 micrometers or less, commonly known as PM2.5.
(b) Any person who violates this section is guilty of a Class F felony."
SECTION 2.(a) The Commission for Public Health (Commission) shall study and make recommendations to the General Assembly regarding exposure of human subjects to harmful or potentially harmful substances during the course of research. As part of its study, the Commission shall specifically consider the following:
(1) Risk factors of human involvement in studies involving exposure to harmful or potentially harmful substances.
(2) Concerns and interests of the scientific community.
(3) Ensuring informed consent in all research studies with appropriate disclosure of all risks to an individual's health, including future side effects of exposure.
(4) Potential legal remedies for exposure to toxins by human subjects, including issues involving access to such remedies.
(5) Any other relevant issues.
SECTION 2.(b) For the purpose of conducting the study described in Section 2(a) of this act, the Commission may exercise all powers provided for under G.S. 120‑19 and G.S. 120‑19.1 through G.S. 120‑19.4. Privileged medical information or protected health information received by the Commission pursuant to the study described in Section 2(a) shall be confidential and is not a public record under G.S. 132‑1.
SECTION 2.(c) The Commission shall report its findings and recommendations to the Joint Legislative Oversight Committee on Health and Human Services by January 1, 2015.
SECTION 3. Section 1 of this act becomes effective July 1, 2013, and applies to offenses committed on or after that date. The remainder of this act is effective when it becomes law.
